News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
201 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (232)
2 (101)
3 (1)
4 (13)
5 (26)
6 (344)
7 (346)
8 (264)
9 (107)
10 (31)
11 (18)
12 (255)
13 (267)
14 (212)
15 (206)
16 (111)
17 (4)
18 (5)
19 (157)
20 (226)
21 (187)
22 (190)
23 (79)
24 (1)
25 (3)
26 (175)
27 (201)
28 (178)
29 (232)
30 (88)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives
BetterLife Pharma Inc. is pleased to announce filing of a PCT patent application along with a U.S. application for lysergic acid diethylamide derivatives, including 2-bromo-LSD.
September 27, 2022
·
4 min read
Pharm Country
Ovid Therapeutics to Present at the Ladenburg Thalmann 2022 Healthcare Conference
Ovid Therapeutics Inc. today announced that management will present at the Ladenburg Thalmann 2022 Healthcare Conference in New York, New York on Thursday, September 29, 2022, at 9:00 a.m. ET.
September 27, 2022
·
3 min read
Drug Development
atai Life Sciences Announces Initiation of Phase 1 Trial for its MDMA Derivative, EMP-01
atai Life Sciences N.V. announced today its Phase 1 study has received regulatory and ethics approvals required from Medsafe and HDEC, respectively, to initiate participant enrollment.
September 27, 2022
·
8 min read
Bio NC
Metabolon Expands Data Access Strategy to Include Health for Life in Singapore (HELIOS) Study
Metabolon, Inc. announced a new partnership with the Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore to identify biomarkers using data from the Health for Life in Singapore study.
September 27, 2022
·
5 min read
Drug Development
Nykode Therapeutics Announces Positive Results from the Phase 1/2 Open Label, Dose Escalation Trial of its T Cell Focused SARS-CoV-2 Vaccine Candidate
Nykode Therapeutics ASA announced positive clinical results from the Phase 1/2 open label, dose escalation trial of Nykode’s T cell focused pan-SARS-CoV-2 vaccine candidate in healthy individuals who were previously vaccinated with an approved mRNA vaccine.
September 27, 2022
·
5 min read
Business
XVIVO Perfusion’s CEO Dag Andersson has Passed Away
XVIVO Perfusion AB’s board of directors announces that CEO Dag Andersson has suddenly passed away.
September 27, 2022
·
1 min read
Business
Labcorp to Announce Third Quarter Financial Results on October 27, 2022
Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the third quarter of 2022 before the market opens on Thursday, Oct. 27, 2022.
September 27, 2022
·
1 min read
Business
Mindset Pharma Provides Strategic Intellectual Property License to Cybin
Mindset Pharma Inc. today announced an exclusive licensing agreement for Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) to acquire intellectual property rights for a subset of Mindset’s preclinical compounds (the “Agreement”).
September 27, 2022
·
4 min read
Business
Invitae Appointed to National Quality Forum Committee on Quality Standards for Healthcare
Invitae today announced the company has received a three-year appointment to a National Quality Forum (NQF) committee that provides input on recommendations for quality standards that impact how healthcare is delivered.
September 27, 2022
·
5 min read
Genetown
Elucidata Raises $16 Million Series A to Reimagine AI Infrastructure for the Life Sciences Industry
Elucidata announced that it has raised $16 million in a Series A fundraising today.
September 27, 2022
·
4 min read
Previous
19 of 21
Next